Cargando…
IL-32θ inhibits stemness and epithelial-mesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancer
Interleukin (IL)-32 is a well-known cytokine associated with inflammation, virus infections and cancer. IL-32θ is a newly identified isoform of IL-32, whose function has yet to be elucidated. In this study, we investigated IL-32θ function in colon cancer stem cells. Using samples from colon cancer p...
Autores principales: | Bak, Yesol, Kwon, Taeho, Bak, In seon, Hong, Jintae, Yu, Dae-Yeul, Yoon, Do-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872787/ https://www.ncbi.nlm.nih.gov/pubmed/26824417 http://dx.doi.org/10.18632/oncotarget.7007 |
Ejemplares similares
-
IL-32θ inhibits monocytic differentiation of leukemia cells by attenuating expression of transcription factor PU.1
por: Kim, Man Sub, et al.
Publicado: (2015) -
A1E reduces stemness and self-renewal in HPV 16-positive cervical cancer stem cells
por: Kwon, Taeho, et al.
Publicado: (2016) -
Interleukin-32θ inhibits tumor-promoting effects of macrophage-secreted CCL18 in breast cancer
por: Pham, Thu-Huyen, et al.
Publicado: (2019) -
Inhibition of IL-13 and IL-13Rα2 Expression by IL-32θ in Human Monocytic Cells Requires PKCδ and STAT3 Association
por: Pham, Thu-Huyen, et al.
Publicado: (2019) -
STK899704 inhibits stemness of cancer stem cells and migration via the FAK-MEK-ERK pathway in HT29 cells
por: Jang, Hui-Ju, et al.
Publicado: (2018)